Modulation of arterial thrombosis by angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade

American Journal of Cardiology

Volumn 82, Issue 9 SUPPL. 2, 1998, Pages 53S-56S

  Mehta, Jawahar L ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOSARTAN; QUINAPRIL;

ACUTE HEART INFARCTION; ANTICOAGULANT THERAPY; ARTERY THROMBOSIS; CONFERENCE PAPER; DRUG EFFICACY; DRUG POTENCY; FIBRINOLYTIC THERAPY; HEART MUSCLE ISCHEMIA; HORMONE INHIBITION; HUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CORONARY THROMBOSIS; HUMANS; PLATELET AGGREGATION INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ANGIOTENSIN; RENIN-ANGIOTENSIN SYSTEM;

EID: 0032548103     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9149(98)00678-x     Document Type: Article

References (11)

1. Mehta JL, Nicolini FA, Donnelly WH, Nichols WW. Platelet-leukocyte-endothelial interactions in coronary artery disease. Am J Cardiol 1992;69(suppl): 8B-13B.
2. Alderman MH, Madhavan S, Ooi W, Cohen H, Sealey JE, Laragh JH. Association of renin-sodium profile with risk of myocardial infarction in patients with hypertension. N Engl J Med 1991;324:1098-1104.
3. Feener EP, Northrup JM, Aiello LP, King GL. Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells. J Clin Invest 1995;95:1353-1362.
4. Ridker PM, Gaboury CL, Conlin PR, Seely EW, Williams GH, Vaughan DE. Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Circulation 1993;87:1969-1973.
5. Vaughan DE, Rouleau J-L, Pfeffer MA. Role of the fibrinolytic system in preventing myocardial infarction. Eur Heart J 1995;16(suppl K):31-36.
6. Swartz SL, Moore TJ. Effect of angiotensin II on collagen-induced platelet activation in normotensive subjects. Thromb Haemost 1990;63:87-90.
7. Brown NJ, Nadeau JH, Vaughan DE. Selective stimulation of tissue-type plasminogen activator (t-PA) in vivo by infusion of bradykinin. Thromb Haemost 1997;77:522-525.
8. Vaughan DE, Rouleau J-L, Ridker PM, Arnold JMO, Menapace FJ, Pfeffer MA, the Heart Study Investigators. Effects of ramipril on plasma fibrinolytic balance in patients with acute anterior myocardial infarction. Circulation 1997; 96:442-447.
9. Goldberg MR, Bradstreet TE, McWilliams EJ, Tanaka WK, Lipert S, Bjornsson TD, Waldman SA, Osborne B, Pivadori L, Lewis G, Blum R, Herman T, Abraham PA, Halstenson CN, Lo M-W, Lu H, Spector R. Biochemical effects of losartan, a nonpeptide angiotensin II receptor antagonist, on the renin-angiotensin-aldosterone system in hypertensive patients. Hypertension 1995;25:37-46.
10. Kurz KD, Main BW, Sandusky GE. Rat model of arterial thrombosis induced by ferric chloride. Thromb Res 1990;60:269-280.
11. Li DY, Weng Y, Yang BC, Zander DS, Saldeen T, Nichols WW, Khan S, Mehta JL. Inhibition of arterial thrombus formation by apo A-1-Milano. Arterioscler Thromb Vasc Biol In press.